Quince Therapeutics Italy Competitors and Similar CompaniesClear all
Quince Therapeutics Italy's competitors and similar companies include NextCure, Keros Therapeutics, ReViral and Sorriso Pharmaceuticals.
 Quince Therapeutics Italy Quince Therapeutics Italy (formerly known as Erydel) is a company that develops technology for the drug delivery of pharmacological agents through red blood cells. |  NextCure NextCure is a biopharmaceutical company focused on discovering and developing next-generation immuno-oncology-based drugs. |  Keros Therapeutics Keros Therapeutics is a biotechnology company that develops therapeutics to treat a wide range of patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta. |  Sorriso Pharmaceuticals Sorriso Pharmaceuticals is a company developing a therapy platform that provides a pipeline of disease-modifying antibodies to treat inflammatory diseases. | ||
Founding Date | Founding Date 2007 | Founding Date 2015 | Founding Date 2015 | Founding Date 2011 | Founding Date 2020 |
Type | Type Subsidiary | Type Public | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Bresso, IT HQ Tre Torri, IT | Locations Beltsville, US HQ | Locations Lexington, US HQ South Wharf, AU | Locations Stevenage, GB HQ Durham, US | Locations HQ |
Employees | Employees 19 | Employees N/A | Employees 1365% increase | Employees 5 | Employees N/A |
Valuation ($) | Valuation ($) N/A | Valuation ($) 39.2 m | Valuation ($) 2.3 b | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Net income | Net income N/A | Net income ($55.7m) (FY, 2024) | Net income ($187.4m) (FY, 2024) | Net income N/A | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 44m (almost 5 years ago) | Latest funding round $ 31m (over 3 years ago) |
Total funding raised | Total funding raised $ 35.6m | Total funding raised $ 160m | Total funding raised $ 90m | Total funding raised $ 121m | Total funding raised $ 31m |
For sources of this data, please see the company profile
View Company Profiles
NextCure
HQ
Beltsville, US
NextCure is a biopharmaceutical company focused on discovering and developing next-generation immuno-oncology-based drugs.
View companyKeros Therapeutics
HQ
Lexington, US
Employees
136↑ 5% increase
Keros Therapeutics is a biotechnology company that develops therapeutics to treat a wide range of patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta.
View company
ReViral
HQ
Stevenage, GB
Employees
5
ReViral is a biotechnology company developing drugs to treat RSV infections.
View companySorriso Pharmaceuticals
HQ
Sorriso Pharmaceuticals is a company developing a therapy platform that provides a pipeline of disease-modifying antibodies to treat inflammatory diseases.
View company